Format

Send to

Choose Destination
Br J Dermatol. 2017 Apr;176(4):1095-1097. doi: 10.1111/bjd.14949. Epub 2017 Feb 7.

Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.

Author information

1
Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, 5000, Odense C, Denmark.
2
Dermatological Investigations Scandinavia, Odense University Hospital, University of Southern Denmark, 5000, Odense C, Denmark.
3
Department of Dermato-Allergology, Herlev and Gentofte Hospital, University of Copenhagen, 2900, Hellerup, Denmark.
4
LEO Pharma A/S, Departments of Clinical Pharmacology and Molecular Biomedicine, 2750, Ballerup, Denmark.
5
Department of Immunology and Microbiology, University of Copenhagen, 2200, Copenhagen N, Denmark.
6
Division of Infection, Inflammation and Immunity, University of Southampton School of Medicine, Southampton, U.K.
7
Centre for Innovative Medical Technology, Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, 5000, Odense C, Denmark.
PMID:
27515376
DOI:
10.1111/bjd.14949
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center